EP3323829
SITE-DIRECTED MODIFICATION OF FVIII
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.11.2005EP published:
15.7.2020EP application number:
17201672.7
EPO information:
European Patent Register
Max expiry date:
13.11.2025
Title:
SITE-DIRECTED MODIFICATION OF FVIII
Timeline
Today
14.11.2005EP application
15.7.2020EP Publication
Owner
Name:
Bayer HealthCare LLCAddress:
555 White Plains Road, Tarrytown, NY 10591, US
Inventor
Name:
PAN, Clark Q.Address:
Sudbury, MA 01776, US
Name:
MURPHY, John E.Address:
Boston, MA 02110, US
Name:
MEI, BaisongAddress:
Waban, MA 02468, US
Name:
STRAUSS, Jonathan S.Address:
San Carlos, CA 94070, US
Name:
TJANDRA, HendriAddress:
Union City, CA 94587-5503, US
Name:
CHEN, JianminAddress:
San Ramon, CA 94583, US
Name:
BARNETT, ThomasAddress:
Willsborough, NJ 08844, US
Name:
TANG, LiangAddress:
Hercules, CA 94547, US
Name:
WANG, DeqianAddress:
Concord, CA 94521, US
Priority
Number:
627277 PDate:
12.11.2004Country:
US
Classification
Categories:
C07K 14/755, A61K 38/00, A61K 38/37, A61K 47/60